Related Experiment Video
Updated: May 26, 2026

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils
Jitka Petrlova1, Trang Duong2, Megan C Cochran2
1Department of Experimental Medical Sciences, Lund University, S-221 84 Lund, Sweden; and.
Abstract:
A number of amyloidogenic variants of apoA-I have been discovered but most have not been analyzed. Previously, we showed that the G26R mutation of apoA-I leads to increased β-strand structure, increased N-terminal protease susceptibility, and increased fibril formation after several days of incubation. In vivo, this and other variants mutated in the N-terminal domain (residues 26 to ∼90) lead to renal and hepatic accumulation. In contrast, several mutations identified within residues 170 to 178 lead to cardiac, laryngeal, and cutaneous protein deposition. Here, we describe the structural changes in the fibrillogenic variant L178H. Like G26R, the initial structure of the protein exhibits altered tertiary conformation relative to wild-type protein along with decreased stability and an altered lipid binding profile. However, in contrast to G26R, L178H undergoes an increase in helical structure upon incubation at 37°C with a half time (t(1/2)) of about 12 days. Upon prolonged incubation, the L178H mutant forms fibrils of a diameter of 10 nm that ranges in length from 30 to 120 nm. These results show that apoA-I, known for its dynamic properties, has the ability to form multiple fibrillar conformations, which may play a role in the tissue-specific deposition of the individual variants.
Insights
The apolipoprotein A-I (apoA-I) L178H variant forms distinct amyloid fibrils with increased helical structure, contributing to tissue-specific protein deposition. This highlights apoA-I
Area of Science:
- Biochemistry and Molecular Biology
- Structural Biology
- Protein Misfolding Diseases
Background:
- Amyloidogenic variants of apolipoprotein A-I (apoA-I) are linked to various protein deposition diseases.
- Previous studies showed the G26R apoA-I variant forms fibrils and causes renal/hepatic accumulation.
- Mutations in different apoA-I regions (N-terminal vs. residues 170-178) result in distinct tissue deposition patterns.
Purpose of the Study:
- To investigate the structural changes and fibril formation of the apoA-I L178H variant.
- To compare the fibrillogenic properties of L178H with the previously studied G26R variant.
- To understand how apoA-I structural dynamics contribute to tissue-specific amyloid deposition.
Main Methods:
- Characterization of the initial structure, stability, and lipid binding of the L178H mutant.
- Incubation of L178H at 37°C to monitor structural changes over time using spectroscopic methods.
- Analysis of fibril morphology (diameter, length) formed by the L178H mutant upon prolonged incubation.
Main Results:
- The L178H variant exhibits altered tertiary conformation, decreased stability, and modified lipid binding compared to wild-type apoA-I.
- Unlike G26R, L178H shows an increase in helical structure upon incubation (t(1/2) ≈ 12 days).
- L178H forms amyloid fibrils (10 nm diameter, 30-120 nm length) after prolonged incubation.
Conclusions:
- ApoA-I possesses the capacity to adopt multiple fibrillar conformations.
- The L178H variant's structural changes and fibril formation mechanism differ from the G26R variant.
- The dynamic nature of apoA-I and its resulting conformations likely influence tissue-specific protein deposition in amyloidosis.
More Related Videos
06:27Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
06:02Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants
Published on: November 28, 2025
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme can...
Fibrous Proteins
Protein Folding